Myositis Associated Antibodies
ACCREDITATION STATUS:
UKAS Schedule of Accreditation
CLINICAL APPLICATION:
Diagnosis of autoimmune disease
ANALYTES:
Analyte | Default Unit |
---|---|
ANA | |
jo-1 | |
Mi-2 | |
PL12 | |
PL7 | |
PM-SCL100 | |
SRP |
MATERIAL PROVIDED: Liquid format. Normal and pathological human serum
DISTRIBUTIONS PER YEAR: 6
SAMPLES PER DISTRIBUTION: 2
FREQUENCY OF DISTRIBUTION: Every 2 months
PROGRAMME OF ANALYSIS:
Data entry is via the web for the submission of results. Data analysis is commenced 21 days after sample despatch. Late returns are accepted and will contribute to the laboratory's cumulative performance statistics.
DATA ANALYSIS:
Qualitative responses are recorded for each analyte and assessed in relation to the designated response
PERFORMANCE SCORING:
MI scoring
PERFORMANCE MONITORING:
Laboratory performance is classified in terms of OMIS over a running analytical window of 6 distributions (12 months)
PERSISTENT POOR PERFORMANCE:
Defined as being in the poor performance category for two or more successive distributions
Immunology, Immunochemistry & Allergy (IIA)
The External Quality Assessment Scheme for Immunology, Immunochemistry & Allergy (IIA) was founded in 1982 by Dr Anthony Milford Ward at Northern General Hospital, Sheffield. In 1982 the Service became known as the UK National External Quality Assessment Service for Immunology, Immunochemistry & Allergy. UK NEQAS IIA is part of the Sheffield Teaching Hospitals NHS Foundation Trust. For the most up-to-date scheme information (including any pilot schemes) please contact the centre directly.
Contact Details
- UK NEQAS Immunology, Immunochemistry & Allergy
- Sheffield Teaching Hospitals NHS Foundation Trust
- PO Box 894
- Sheffield
- S5 7YT
Immunology, Immunochemistry & Allergy (IIA)
- Telephone: +44 (0) 114 271 5715
- Email: ukneqas@immqas.org.uk
- Web: https://www.immqas.org.uk/